Compare Cadila Healthcare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ALKEM LABORATORIES - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE ALKEM LABORATORIES CADILA HEALTHCARE/
ALKEM LABORATORIES
 
P/E (TTM) x 14.5 - - View Chart
P/BV x 2.8 6.5 43.7% View Chart
Dividend Yield % 1.5 0.7 216.2%  

Financials

 CADILA HEALTHCARE   ALKEM LABORATORIES
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
ALKEM LABORATORIES
Mar-16
CADILA HEALTHCARE/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs5581,589 35.1%   
Low Rs3621,232 29.3%   
Sales per share (Unadj.) Rs116.3417.5 27.9%  
Earnings per share (Unadj.) Rs17.956.3 31.7%  
Cash flow per share (Unadj.) Rs23.164.7 35.7%  
Dividends per share (Unadj.) Rs3.5012.70 27.6%  
Dividend yield (eoy) %0.80.9 84.6%  
Book value per share (Unadj.) Rs85.4292.9 29.2%  
Shares outstanding (eoy) m1,023.74119.57 856.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.03.4 117.0%   
Avg P/E ratio x25.725.1 102.7%  
P/CF ratio (eoy) x19.921.8 91.2%  
Price / Book Value ratio x5.44.8 111.8%  
Dividend payout %19.622.6 86.8%   
Avg Mkt Cap Rs m470,664168,653 279.1%   
No. of employees `00011.8NA-   
Total wages/salary Rs m18,5459,171 202.2%   
Avg. sales/employee Rs Th10,072.7NM-  
Avg. wages/employee Rs Th1,569.1NM-  
Avg. net profit/employee Rs Th1,547.7NM-  
INCOME DATA
Net Sales Rs m119,04949,915 238.5%  
Other income Rs m1,1321,645 68.8%   
Total revenues Rs m120,18151,561 233.1%   
Gross profit Rs m28,4758,482 335.7%  
Depreciation Rs m5,3881,006 535.7%   
Interest Rs m911671 135.8%   
Profit before tax Rs m23,3088,451 275.8%   
Minority Interest Rs m628-114 -551.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,6441,606 351.4%   
Profit after tax Rs m18,2926,731 271.7%  
Gross profit margin %23.917.0 140.8%  
Effective tax rate %24.219.0 127.4%   
Net profit margin %15.413.5 113.9%  
BALANCE SHEET DATA
Current assets Rs m82,00527,062 303.0%   
Current liabilities Rs m60,72015,324 396.3%   
Net working cap to sales %17.923.5 76.0%  
Current ratio x1.41.8 76.5%  
Inventory Days Days7367 110.0%  
Debtors Days Days9841 238.1%  
Net fixed assets Rs m83,70312,610 663.8%   
Share capital Rs m1,024239 428.3%   
"Free" reserves Rs m86,42134,490 250.6%   
Net worth Rs m87,44535,027 249.7%   
Long term debt Rs m25,5511,212 2,108.9%   
Total assets Rs m180,65354,387 332.2%  
Interest coverage x26.613.6 195.4%   
Debt to equity ratio x0.30 844.7%  
Sales to assets ratio x0.70.9 71.8%   
Return on assets %10.613.6 78.1%  
Return on equity %20.919.2 108.9%  
Return on capital %22.024.9 88.5%  
Exports to sales %012.9 0.0%   
Imports to sales %03.1 0.0%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs mNA1,540 0.0%   
Fx inflow Rs m42,6836,563 650.3%   
Fx outflow Rs m11,2423,012 373.3%   
Net fx Rs m31,4413,552 885.3%   
CASH FLOW
From Operations Rs m9,1937,259 126.7%  
From Investments Rs m-9,7371,864 -522.3%  
From Financial Activity Rs m515-9,273 -5.6%  
Net Cashflow Rs m-29-150 19.3%  

Share Holding

Indian Promoters % 74.8 66.9 111.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 33.1 25.1%  
FIIs % 5.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 0.0 -  
Shareholders   44,069 68,381 64.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   J.B.CHEMICALS  SUVEN LIFESCIENCES  CIPLA  ELDER PHARMA  VENUS REMEDIES  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Rising Petrol and Diesel Prices, DHFL Saga, and Top Cues in Focus Today(Pre-Open)

Indian share markets ended their trading session marginally higher yesterday. On the sectoral front, gains were seen in the metal sector and realty sector.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Sep 18, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - SHASUN PHARMA COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS